General practitioners' perceptions of pharmacists' new services in New Zealand
- PMID: 22359183
- DOI: 10.1007/s11096-012-9617-3
General practitioners' perceptions of pharmacists' new services in New Zealand
Abstract
Background: In recent years, the pharmacy profession has moved towards more patient-oriented services. Some examples are medication review, screening and monitoring for disease, and prescribing. The new services are intended to be in close collaboration with general practitioners (GPs) yet little is known of how GPs in New Zealand perceive these new services. Objective To examine GPs' perceptions of pharmacists' new services.
Setting: Study was undertaken at GPs' practices in two localities in New Zealand.
Methods: Qualitative, face to face, semi-structured interviews were undertaken of 18 GPs. The cohort included GPs with less/more than 20 years of practice, and GPs who had experience of working in localities where some patients had undergone a medication review (Medicines Use Review, MUR) by community pharmacists. GPs were asked to share their perceptions about pharmacists providing some new services. Data were thematically analysed with constant comparison using NVivo 8 software. Using a business strategic planning approach, themes were further analysed and interpreted as the services' potential Strengths, Weaknesses, Opportunities and Threats (SWOTs).
Main outcomes measure: GPs' perceptions of pharmacists' new services.
Results: GPs were more supportive of pharmacists' playing active roles in medication review and less supportive of pharmacists practising screening-monitoring and prescribing. Discussions Pharmacists' knowledge and skills in medication use and the perceived benefits of the services to patients were considered the potential strengths of the services. Weaknesses centred around potential patient confusion and harm, conflict and irritation to GPs' practice, and the potential to fragment patient-care. Opportunities were the possibilities of improving communication, and having a close collaboration and integration with GPs' practice. Apparent threats were the GPs' perceptions of a related, and not renumerated, increase in their workloads, and the perception of limited benefit to patients.
Conclusion: Pharmacists should exploit their own strengths and the potential opportunities for these services, and reduce any weaknesses and threats. A possible strategic plan should include increased effective communication, piloting services, and the integration of some services into medical practices.
Similar articles
-
General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.J Prim Health Care. 2013 Sep 1;5(3):223-33. J Prim Health Care. 2013. PMID: 23998173
-
Community pharmacists' perceptions of services that benefit older people in New Zealand.Int J Clin Pharm. 2012 Apr;34(2):342-50. doi: 10.1007/s11096-012-9612-8. Epub 2012 Feb 11. Int J Clin Pharm. 2012. PMID: 22328011
-
Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.Health Soc Care Community. 2019 May;27(3):565-598. doi: 10.1111/hsc.12618. Epub 2018 Jul 26. Health Soc Care Community. 2019. PMID: 30047617
-
General practitioners' perceptions of pharmacists working in general practice: a qualitative interview study.Fam Pract. 2023 Mar 28;40(2):377-386. doi: 10.1093/fampra/cmac115. Fam Pract. 2023. PMID: 36242543 Free PMC article.
-
Investigating general practitioner engagement with pharmacists in Home Medicines Review.J Interprof Care. 2015;29(5):469-75. doi: 10.3109/13561820.2015.1012253. Epub 2015 Feb 18. J Interprof Care. 2015. PMID: 25692718 Review.
Cited by
-
Pharmacy Services beyond the Basics: A Qualitative Study to Explore Perspectives of Pharmacists towards Basic and Enhanced Pharmacy Services in Pakistan.Int J Environ Res Public Health. 2020 Mar 31;17(7):2379. doi: 10.3390/ijerph17072379. Int J Environ Res Public Health. 2020. PMID: 32244475 Free PMC article.
-
"Prescribing for the whole person": A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand.BMC Health Serv Res. 2023 Oct 4;23(1):1058. doi: 10.1186/s12913-023-09877-8. BMC Health Serv Res. 2023. PMID: 37794403 Free PMC article.
-
Qualitative study of medication review in Flanders, Belgium among community pharmacists and general practitioners.Int J Clin Pharm. 2021 Oct;43(5):1173-1182. doi: 10.1007/s11096-020-01224-9. Epub 2021 Jan 23. Int J Clin Pharm. 2021. PMID: 33484398
-
The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.Int J Clin Pharm. 2015 Oct;37(5):834-43. doi: 10.1007/s11096-015-0127-y. Epub 2015 May 12. Int J Clin Pharm. 2015. PMID: 25964140
-
The pharmacist as safety net: an interview-based study of the intersecting dependencies between doctors and pharmacists.J Pharm Policy Pract. 2023 Mar 9;16(1):40. doi: 10.1186/s40545-023-00536-1. J Pharm Policy Pract. 2023. PMID: 36894977 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources